Catalyst Wire Dossier Catalyst Wire Dossier

MMRV vaccine (AMP)

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MMRV vaccine (AMP), covering 2014-07-02 to 2014-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) [Phase 3]

See pricing